A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort

被引：2
|
作者：
Ruiz-Antoran, Belen [1 ]
Sancho-Lopez, Aranzazu [1 ]
Torres, Ferran [2 ,3 ]
Fernandez-Cruz, Ana [4 ]
机构：
[1] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Segovia de, Clin Pharmacol Dept, Madrid, Spain
[2] Hosp Clin Barcelona, August Pi & Sunyer Biomed Res Inst, Med Stat Core Facil, Barcelona, Spain
[3] Autonomous Univ Barcelona, Biostat Unit, Fac Med, Barcelona, Spain
[4] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Segovia de, Internal Med Dept, Infect Dis Unit, Madrid, Spain
来源：
INFECTIOUS DISEASES AND THERAPY | 2021年 / 10卷 / 03期
关键词：
Tocilizumab; Steroids; COVID-19; SARS-CoV-2; Mortality;
D O I：
10.1007/s40121-021-00444-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1811 / 1813
页数：3
相关论文
共 50 条
  • [31] Response to Letter to the Editor: Taste and Smell Dysfunction in COVID-19 Patients
    de Souza, Sara Martinelli
    Panichelli, Barbara Santos
    Spitz, Mariana
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2021, 130 (04): : 434 - 435
  • [32] Author's response to: "Letter to the Editor: The atherogenic index of plasma as a predictor of mortality in patients with COVID-19"
    Yildirim, Ozge Turgay
    Kaya, Seyhmus
    HEART & LUNG, 2023, 59
  • [33] Tocilizumab for reduction of mortality in severe COVID-19 patients: How should we GRADE it?
    Trkulja, Vladimir
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) : 3539 - 3541
  • [34] Letter to Editor: The Prevalence of Hyperamylasemia and Its Relationship With Mortality in COVID-19 Patients
    Ataee, Zahra
    Ziaee, Maliheh
    Yaghoubi, Atieh
    Ataei, Leila
    Solemanpour, Saman
    INTERNATIONAL JOURNAL OF MEDICAL TOXICOLOGY AND FORENSIC MEDICINE, 2021, 11 (03):
  • [35] Letter to the Editor: The atherogenic index of plasma as a predictor of mortality in patients with COVID-19
    Qazi, Maida
    Kumar, Satesh
    Khatri, Mahima
    HEART & LUNG, 2023, 57 : 301 - 301
  • [36] Letter to the Editor Regarding "Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity" Response
    不详
    IRANIAN JOURNAL OF IMMUNOLOGY, 2024, 21 (01) : 102 - 102
  • [37] Commentary on the Letter to the Editor regarding "Dysphonia in COVID-19 patients: Direct or indirect symptom?
    Al-Ani, Raid M.
    Rashid, Rasheed Ali
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (01)
  • [38] Letter to the editor regarding "Nasal inflammatory profile in patients with COVID-19 olfactory dysfunctions"
    Min, Hyun Jin
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (11) : 1451 - 1452
  • [39] Letter to the Editor Regarding "Aneurysmal Subarachnoid Hemorrhage in COVID-19 Patients: A Case Series"
    Kanat, Ayhan
    WORLD NEUROSURGERY, 2021, 154 : 199 - 199
  • [40] The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study
    Aljuhani, Ohoud
    Al Sulaiman, Khalid
    Korayem, Ghazwa
    Alharbi, Aisha
    Altebainawi, Ali F.
    Aldkheel, Shatha A.
    Alotaibi, Sarah G.
    Vishwakarma, Ramesh
    Alshareef, Hanan
    Alsohimi, Samiah
    AlFaifi, Mashael
    Al Shaya, Abdulrahman
    Alhaidal, Haifa A.
    Alsubaie, Raghad M.
    Alrashidi, Hessah
    Albarqi, Khalid J.
    Alangari, Dalal T.
    Alanazi, Reem M.
    Altaher, Noora M.
    Al-Dorzi, Hasan M.
    RENAL FAILURE, 2023, 45 (02)
12345